BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

Ann: CaPTHymone Clinical Trial Update , page-10

  1. 570 Posts.
    Re value of the company, it should slowly gain traction as the word gets out there that this is an opportunity to get in at the ground floor.Just need a couple of backers and we will be seeing 5 cents easily.Get rid of the termites I. Lahore or what ever they call themselves and move forward with real believers like us .I have been on little company's like this before don't buy to many put them in the bottom draw and give them to the kids. Or in your super they can be the difference between a good time and a bloody ripper time.Hang on to your hats more news will re rate this baby and we will all be grinners .dyor of course.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.